The Brussels Declaration: the need for change in asthma management

S Holgate, H Bisgaard, L Bjermer, T Haahtela, J Haughney, R Horne, A McIvor, S Palkonen, D B Price, M Thomas, E Valovirta, U Wahn

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Asthma is a highly prevalent condition across Europe and numerous guidelines have been developed to optimise management. However, asthma can be neither cured nor prevented, treatment choices are limited and many patients have poorly controlled or uncontrolled asthma. The Brussels Declaration on Asthma, sponsored by The Asthma, Allergy and Inflammation Research Charity, was developed to call attention to the shortfalls in asthma management and to urge European policy makers to recognise that asthma is a public health problem that should be a political priority. The Declaration urges recognition and action on the following points: the systemic inflammatory component of asthma should be better understood and considered in assessments of treatment efficacy; current research must be communicated and responded to quickly; the European Medicines Agency guidance note on asthma should be updated; "real world" studies should be funded and results used to inform guidelines; variations in care across Europe should be addressed; people with asthma should participate in their own care; the impact of environmental factors should be understood; and targets should be set for improvement. The present paper reviews the evidence supporting the need for change in asthma management and summarises the ten key points contained in the Brussels Declaration.

Original languageEnglish
Pages (from-to)1433-1442
Number of pages10
JournalEuropean Respiratory Journal
Volume32
Issue number6
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Asthma
Guidelines
Charities
Administrative Personnel
Research
Hypersensitivity
Public Health
Inflammation

Keywords

  • adult
  • asthma
  • Belgium
  • child
  • clinical competence
  • disease management
  • Europe
  • humans
  • inflammation
  • outcome assessment (health care)
  • prevalence
  • pulmonary medicine
  • registries

Cite this

Holgate, S., Bisgaard, H., Bjermer, L., Haahtela, T., Haughney, J., Horne, R., ... Wahn, U. (2008). The Brussels Declaration: the need for change in asthma management. European Respiratory Journal, 32(6), 1433-1442. https://doi.org/10.1183/09031936.00053108

The Brussels Declaration : the need for change in asthma management. / Holgate, S; Bisgaard, H; Bjermer, L; Haahtela, T; Haughney, J; Horne, R; McIvor, A; Palkonen, S; Price, D B; Thomas, M; Valovirta, E; Wahn, U.

In: European Respiratory Journal, Vol. 32, No. 6, 12.2008, p. 1433-1442.

Research output: Contribution to journalArticle

Holgate, S, Bisgaard, H, Bjermer, L, Haahtela, T, Haughney, J, Horne, R, McIvor, A, Palkonen, S, Price, DB, Thomas, M, Valovirta, E & Wahn, U 2008, 'The Brussels Declaration: the need for change in asthma management', European Respiratory Journal, vol. 32, no. 6, pp. 1433-1442. https://doi.org/10.1183/09031936.00053108
Holgate, S ; Bisgaard, H ; Bjermer, L ; Haahtela, T ; Haughney, J ; Horne, R ; McIvor, A ; Palkonen, S ; Price, D B ; Thomas, M ; Valovirta, E ; Wahn, U. / The Brussels Declaration : the need for change in asthma management. In: European Respiratory Journal. 2008 ; Vol. 32, No. 6. pp. 1433-1442.
@article{cb4c03cf618b4b699a25cf2576de9278,
title = "The Brussels Declaration: the need for change in asthma management",
abstract = "Asthma is a highly prevalent condition across Europe and numerous guidelines have been developed to optimise management. However, asthma can be neither cured nor prevented, treatment choices are limited and many patients have poorly controlled or uncontrolled asthma. The Brussels Declaration on Asthma, sponsored by The Asthma, Allergy and Inflammation Research Charity, was developed to call attention to the shortfalls in asthma management and to urge European policy makers to recognise that asthma is a public health problem that should be a political priority. The Declaration urges recognition and action on the following points: the systemic inflammatory component of asthma should be better understood and considered in assessments of treatment efficacy; current research must be communicated and responded to quickly; the European Medicines Agency guidance note on asthma should be updated; {"}real world{"} studies should be funded and results used to inform guidelines; variations in care across Europe should be addressed; people with asthma should participate in their own care; the impact of environmental factors should be understood; and targets should be set for improvement. The present paper reviews the evidence supporting the need for change in asthma management and summarises the ten key points contained in the Brussels Declaration.",
keywords = "adult, asthma, Belgium, child, clinical competence, disease management, Europe, humans, inflammation, outcome assessment (health care), prevalence, pulmonary medicine, registries",
author = "S Holgate and H Bisgaard and L Bjermer and T Haahtela and J Haughney and R Horne and A McIvor and S Palkonen and Price, {D B} and M Thomas and E Valovirta and U Wahn",
year = "2008",
month = "12",
doi = "10.1183/09031936.00053108",
language = "English",
volume = "32",
pages = "1433--1442",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - The Brussels Declaration

T2 - the need for change in asthma management

AU - Holgate, S

AU - Bisgaard, H

AU - Bjermer, L

AU - Haahtela, T

AU - Haughney, J

AU - Horne, R

AU - McIvor, A

AU - Palkonen, S

AU - Price, D B

AU - Thomas, M

AU - Valovirta, E

AU - Wahn, U

PY - 2008/12

Y1 - 2008/12

N2 - Asthma is a highly prevalent condition across Europe and numerous guidelines have been developed to optimise management. However, asthma can be neither cured nor prevented, treatment choices are limited and many patients have poorly controlled or uncontrolled asthma. The Brussels Declaration on Asthma, sponsored by The Asthma, Allergy and Inflammation Research Charity, was developed to call attention to the shortfalls in asthma management and to urge European policy makers to recognise that asthma is a public health problem that should be a political priority. The Declaration urges recognition and action on the following points: the systemic inflammatory component of asthma should be better understood and considered in assessments of treatment efficacy; current research must be communicated and responded to quickly; the European Medicines Agency guidance note on asthma should be updated; "real world" studies should be funded and results used to inform guidelines; variations in care across Europe should be addressed; people with asthma should participate in their own care; the impact of environmental factors should be understood; and targets should be set for improvement. The present paper reviews the evidence supporting the need for change in asthma management and summarises the ten key points contained in the Brussels Declaration.

AB - Asthma is a highly prevalent condition across Europe and numerous guidelines have been developed to optimise management. However, asthma can be neither cured nor prevented, treatment choices are limited and many patients have poorly controlled or uncontrolled asthma. The Brussels Declaration on Asthma, sponsored by The Asthma, Allergy and Inflammation Research Charity, was developed to call attention to the shortfalls in asthma management and to urge European policy makers to recognise that asthma is a public health problem that should be a political priority. The Declaration urges recognition and action on the following points: the systemic inflammatory component of asthma should be better understood and considered in assessments of treatment efficacy; current research must be communicated and responded to quickly; the European Medicines Agency guidance note on asthma should be updated; "real world" studies should be funded and results used to inform guidelines; variations in care across Europe should be addressed; people with asthma should participate in their own care; the impact of environmental factors should be understood; and targets should be set for improvement. The present paper reviews the evidence supporting the need for change in asthma management and summarises the ten key points contained in the Brussels Declaration.

KW - adult

KW - asthma

KW - Belgium

KW - child

KW - clinical competence

KW - disease management

KW - Europe

KW - humans

KW - inflammation

KW - outcome assessment (health care)

KW - prevalence

KW - pulmonary medicine

KW - registries

U2 - 10.1183/09031936.00053108

DO - 10.1183/09031936.00053108

M3 - Article

C2 - 19043008

VL - 32

SP - 1433

EP - 1442

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 6

ER -